• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Neuralstem Inc

+ Add to Watchlist

7NS:GR

2.507 EUR 0.069 2.68%

As of 02:02:14 ET on 09/19/2014.

Snapshot for Neuralstem Inc (7NS)

Open: 2.507 Day's Range: 2.507 - 2.507 Volume: 0
Previous Close: 2.576 52wk Range: 1.585 - 3.417 1-Yr Rtn: +28.10%

Stock Chart for 7NS

No chart data available.
  • 7NS:GR 2.507
  • 1D
  • 1M
  • 1Y
2.576
Interactive 7NS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 7NS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.2300
Est. PEG Ratio -
Market Cap (M EUR) 217.70
Shares Outstanding (M) 86.84
30 Day Average Volume 222
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 7NS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 7NS

Neuralstem Inc. provides medical research services. The Company develops and commercializes clinical treatment for central nervous system diseases. Neuralstem serves the medical field worldwide.

Karl JoheChairman/Chief Scientific OfcrI Richard GarrPresident/CEO/CFO/Gen Counsel
Thomas Hazel "Tom"Senior VP:ResearchSusan RoushInvestor Relations
More Company Profile & Key Executives for 7NS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil